1 report

  • AVEO Pharmaceuticals, Inc. - Research and Development Overview

R& D Progress Research and Development Brief GP-## Product Description GP-## (FGFR## inhibitory monoclonal antibody) is under development for the treatment of cancer.

  • Pharmaceutical
  • Research And Development
  • Targeted Therapy
  • Therapy
  • AVEO Pharmaceuticals, Inc.